戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  lymphomas and 3 months for intermediate- to high-grade lymphomas).
2  cycle protein expression similar to that of high-grade lymphoma.
3 lls, often culminating in the development of high-grade lymphoma.
4 ay range from benign lymphoid hyperplasia to high-grade lymphoma.
5 of patients with poor-risk intermediate- and high-grade lymphoma.
6 tion in C57BL/6 mice resulted in progressive high-grade lymphoma.
7 ic mice develop acute lymphoblastic leukemia/high-grade lymphoma.
8 pre-B cells and acute lymphoblastic leukemia/high-grade lymphoma.
9 trate extended cell survival and progress to high-grade lymphomas.
10 ion of TIMP-1 by normal reactive B cells and high-grade lymphomas.
11 son to its ability to detect intermediate or high-grade lymphomas.
12      Among 19 patients with intermediate- or high-grade lymphoma, 13 had diffuse large cell lymphoma.
13  11 with intermediate-grade lymphoma, 4 with high-grade lymphoma and 12 with Hodgkin's lymphoma) pati
14  expressed in a subset of both low-grade and high-grade lymphomas; and (iii) there was extensive down
15 h external beam radiotherapy (EBRT), whereas high-grade lymphomas (DLBCL and MCL) were treated with c
16 f malignant degeneration into an aggressive, high-grade lymphoma in one patient indicates the maligna
17 owth factor that is expressed in a number of high-grade lymphomas, including MCL-BV.
18  induce pre-B-cell proliferation followed by high-grade lymphoma/leukemia.
19 phenotypic features and that it represents a high-grade lymphoma much closer to BL than DLBCL.
20 ry myelodysplasia, whereas transformation to high-grade lymphoma occurred in 3 patients who had recei
21                        Current treatments of high-grade lymphoma often have curative potential, but u
22                                              High-grade lymphoma was diagnosed in 29 patients (83%).
23 ival for the patients with intermediate- and high-grade lymphoma were 47% and 53%, respectively.
24  the optimum time of imaging for thallium in high-grade lymphoma, whether delayed imaging is essentia